Development of comprehensive disease assessment in systemic vasculitis
(2007) In Annals of the Rheumatic Diseases 66(3). p.283-292- Abstract
- The systemic vasculitides are multisystem disorders with considerable mortality and morbidity and frequent relapses. In the absence of reliable serological markers, accurate clinical tools are required to assess disease activity and damage for treatment decisions, and for the performance of clinical trials. This article reviews and summarises the development and use of disease assessment tools for determining activity and damage in systemic vasculitis and reports ongoing initiatives for further development of disease assessment tools. A literature search was conducted using PubMed and reference lists for vasculitis, assessment, clinical trials, outcome and prognosis. The findings indicate that comprehensive disease assessment in vasculitis... (More)
- The systemic vasculitides are multisystem disorders with considerable mortality and morbidity and frequent relapses. In the absence of reliable serological markers, accurate clinical tools are required to assess disease activity and damage for treatment decisions, and for the performance of clinical trials. This article reviews and summarises the development and use of disease assessment tools for determining activity and damage in systemic vasculitis and reports ongoing initiatives for further development of disease assessment tools. A literature search was conducted using PubMed and reference lists for vasculitis, assessment, clinical trials, outcome and prognosis. The findings indicate that comprehensive disease assessment in vasculitis requires documentation of disease activity, chronic irreversible damage and impairment of function. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1138505
- author
- Flossmann, Oliver ; Bacon, Paul ; de Groot, Kirsten ; Jayne, David ; Rasmussen, Niels ; Seo, Philip ; Westman, Kerstin LU and Luqmani, Raashid
- organization
- publishing date
- 2007
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Annals of the Rheumatic Diseases
- volume
- 66
- issue
- 3
- pages
- 283 - 292
- publisher
- BMJ Publishing Group
- external identifiers
-
- pmid:16728460
- scopus:34147224220
- ISSN
- 1468-2060
- DOI
- 10.1136/ard.2005.051078
- language
- English
- LU publication?
- yes
- id
- 08918497-93ac-4a9e-9b9d-178e9dc32a57 (old id 1138505)
- date added to LUP
- 2016-04-01 17:15:11
- date last changed
- 2022-02-05 21:45:51
@article{08918497-93ac-4a9e-9b9d-178e9dc32a57,
abstract = {{The systemic vasculitides are multisystem disorders with considerable mortality and morbidity and frequent relapses. In the absence of reliable serological markers, accurate clinical tools are required to assess disease activity and damage for treatment decisions, and for the performance of clinical trials. This article reviews and summarises the development and use of disease assessment tools for determining activity and damage in systemic vasculitis and reports ongoing initiatives for further development of disease assessment tools. A literature search was conducted using PubMed and reference lists for vasculitis, assessment, clinical trials, outcome and prognosis. The findings indicate that comprehensive disease assessment in vasculitis requires documentation of disease activity, chronic irreversible damage and impairment of function.}},
author = {{Flossmann, Oliver and Bacon, Paul and de Groot, Kirsten and Jayne, David and Rasmussen, Niels and Seo, Philip and Westman, Kerstin and Luqmani, Raashid}},
issn = {{1468-2060}},
language = {{eng}},
number = {{3}},
pages = {{283--292}},
publisher = {{BMJ Publishing Group}},
series = {{Annals of the Rheumatic Diseases}},
title = {{Development of comprehensive disease assessment in systemic vasculitis}},
url = {{http://dx.doi.org/10.1136/ard.2005.051078}},
doi = {{10.1136/ard.2005.051078}},
volume = {{66}},
year = {{2007}},
}